(:CVLB)

Feb 22, 2021 03:30 am ET
Conversion Labs Begins Trading Under New Company Name, LifeMD, and Ticker Symbol, LFMD
Conversion Labs, Inc. (NASDAQ: CVLB) (NASDAQ: LFMD), a leading direct-to-patient telehealth company, will begin trading at the opening of the market today under its new name, LifeMD, Inc., and Nasdaq ticker symbol, LFMD. The stock’s new CUSIP...
Feb 17, 2021 09:25 am ET
Conversion Labs to Present at the BTIG Virtual MedTech, Digital Health, Life Science & Diagnostic Tools Conference on February 18, 2021
Conversion Labs, Inc. (NASDAQ: CVLB), a leading direct-to-patient telehealth company, has been invited to present at the BTIG Virtual MedTech, Digital Health, Life Science & Diagnostic Tools Conference being held on February 17-19, 2021....
Feb 12, 2021 08:30 am ET
Conversion Labs to Become Life MD™ with Launch of New Concierge Telehealth Services
Conversion Labs, Inc. (NASDAQ: CVLB), a leading direct-to-patient telehealth company, will change its name to Life MD™ on February 22, followed by the official launch of its subscription-based primary care and concierge services offering designed...
Feb 05, 2021 08:31 am ET
Conversion Labs Appoints Seasoned Financial and Operational Executive, Marc Benathen, as Chief Financial Officer
Conversion Labs, Inc. (NASDAQ: CVLB), a leading direct-to-consumer telemedicine company, has appointed Marc Benathen as chief financial officer, effective March 1. He succeeds Juan Manuel Piñeiro Dagnery, who will continue as chief revenue officer....
Jan 28, 2021 10:30 am ET
Conversion Labs Increases Stake in Fast-Growing SaaS Subsidiary
Conversion Labs, Inc. (NASDAQ: CVLB), a leading direct-to-consumer telemedicine company, has increased its stake in its legacy LegalSimpli Software subsidiary from 51% to 82.6%, largely from the conversion of long-term debt held by Conversion Labs...
Jan 19, 2021 08:31 am ET
Conversion Labs Expects 2020 Revenue up 205% to Record $38.0 Million, Subscription ARR up 525% to $26.0 Million
Conversion Labs, Inc. (NASDAQ: CVLB), a leading direct-to-consumer telemedicine company, reported preliminary unaudited results for its fourth quarter and full year ended December 31, 2020. Revenue for the fourth quarter is expected to total $13.6...
Jan 11, 2021 08:31 am ET
Conversion Labs Appoints Leading Telehealth Professional, Dr. Anthony Puopolo, as Chief Medical Officer
Conversion Labs, Inc. (NASDAQ: CVLB), a direct-to-consumer telemedicine company, has appointed licensed personal care and wellness physician and psychiatrist, Dr. Anthony Puopolo, to the new position of chief medical officer. Dr. Puopolo will be...
Jan 06, 2021 04:01 pm ET
Conversion Labs to Present at the H.C. Wainwright Virtual BioConnect Conference on January 11, 2021
Conversion Labs, Inc. (NASDAQ: CVLB), a direct-to-consumer telemedicine company, has been invited to present at H.C. Wainwright’s BioConnect Conference being held virtually on January 11-14, 2021. The company’s presentation will be available...
Jan 05, 2021 10:15 am ET
Conversion Labs Appoints Digital Marketing Executive, Bryant Hussey, as Chief Digital Officer
Conversion Labs, Inc. (NASDAQ: CVLB), a direct-to-consumer telemedicine company, has appointed digital marketing expert and industry thought-leader, Bryant Hussey, to the new position of chief digital officer. He will lead the company’s marketing...
Dec 15, 2020 08:31 am ET
Conversion Labs Annualized Revenue Run-Rate Hits $53.9 Million, up 332% vs. 2019, Driven by Subscriptions to an Expanding Suite of Telehealth Brands
Conversion Labs, Inc. (NASDAQ: CVLB), a direct-to-consumer telemedicine and wellness company, reported its annualized revenue run-rate reached a record $53.9 million in November, up 332% versus $12.5 million for all of 2019. The run-rate is based...
Dec 11, 2020 08:31 am ET
Conversion Labs Launches Veritas MD™ Telehealth Platform, Delivering Greater Access to Growing Portfolio of Industry-Leading, Direct-to-Consumer Pharmacy and Wellness Brands
Conversion Labs, Inc. (NASDAQ: CVLB), a direct-to-consumer telemedicine and wellness company, has officially launched its new Veritas MD telehealth platform, opening the door to greater market expansion with a growing portfolio of industry leading,...
Dec 09, 2020 08:31 am ET
Conversion Labs Approved for Nasdaq Capital Market Listing; Trading to Commence Tomorrow, December 10, 2020, Under the Symbol, CVLB
Conversion Labs, Inc. (OTCQB: CVLB), a direct-to-consumer telemedicine and wellness company, has received approval to uplist to the Nasdaq Capital Market®. The company’s common stock will commence trading on the exchange at the opening of the...
Nov 20, 2020 07:31 am ET
Conversion Labs Appoints Expert Life Sciences Attorney, Eric H. Yecies, as Chief Compliance Officer and General Counsel
Conversion Labs, Inc. (OTCQB: CVLB), a direct-to-consumer telemedicine and wellness company, has appointed expert Life Sciences attorney, Eric H. Yecies, to the new position of chief compliance officer and general counsel. Yecies is a highly...
Nov 16, 2020 04:01 pm ET
Conversion Labs Q3 2020 Revenue up 252% to Record $11.0 Million
Conversion Labs, Inc. (OTCQB: CVLB) (OTCQB: CVLBD), a direct-to-consumer telemedicine and wellness company, reported results for the third quarter and first nine months ended September 30, 2020. All quarterly and first nine-month comparisons are to...
Nov 10, 2020 07:31 am ET
Conversion Labs Appoints WEX CFO and Former Revlon CFO, Roberto Simon, to Board of Directors
Conversion Labs, Inc. (OTCQB: CVLB) (OTCQB: CVLBD), a direct-to-consumer telemedicine and wellness company, has appointed Roberto Simon to its board of directors and as the chair of its audit committee. Following his appointment, the board now has...
Nov 09, 2020 01:00 pm ET
Conversion Labs to Host Third Quarter Conference Call on Monday, November 16, 2020 at 4:30 p.m. ET
Conversion Labs, Inc. (OTCQB: CVLB) (OTCQB: CVLBD), a direct-to-consumer telemedicine and wellness company, will hold a conference call on Monday, November 16, 2020 at 4:30 p.m. Eastern time to discuss its results for the third quarter ended...
Nov 04, 2020 09:00 am ET
Conversion Labs Closes Initial Round of $15 Million Private Placement with Institutional Investors, Advances Toward Nasdaq Uplisting
Conversion Labs, Inc. (OTCQB: CVLB) (OTCQB: CVLBD), a direct-to-consumer telemedicine and wellness company, has closed on approximately $14.5 million of a $15 million private placement with institutional investors at a purchase price of $4.75 per...
Oct 26, 2020 07:35 am ET
Conversion Labs Licenses Restorsea Technology Platform for Launch of New Teledermatology Line, Nava MD™
Conversion Labs, Inc. (OTCQB: CVLB) (OTCQB: CVLBD), a direct-to-consumer telemedicine and wellness company, has signed a licensing agreement with Restorsea, a leading medical grade skincare technology platform. Conversion Labs plans to use...
Oct 21, 2020 07:35 am ET
Conversion Labs Appoints Former White House Physician and U.S. Navy Rear Admiral, Dr. Connie Mariano, to Board of Directors
Conversion Labs, Inc. (OTCQB: CVLB), a direct-to-consumer telemedicine and wellness company, has appointed healthcare veteran, Dr. Connie Mariano, to its board of directors. Following her appointment, the board will have eight members, with five...
Oct 14, 2020 07:35 am ET
Conversion Labs Reverse Splits Common Shares 1-for-5 in Preparation for Nasdaq Listing
Conversion Labs, Inc. (OTCQB: CVLB), a direct-to-consumer telemedicine and wellness company, will effect a 1-for-5 reverse split of its common stock effective prior to the opening of the market today, Wednesday, October 14, 2020.  The reverse...
Oct 12, 2020 07:35 am ET
Conversion Labs Expects Q3 2020 Record Revenue of $11.2 Million, up 254%; Subscription ARR Hits $19.3 million, up 458%
Conversion Labs, Inc. (OTCQB: CVLB), a direct-to-consumer telemedicine and wellness company, reported preliminary unaudited results for its third quarter ended September 30, 2020. Revenues for the third quarter are expected to total...
Sep 16, 2020 07:35 am ET
Conversion Labs Closes $3.5 Million Equity Investment, Submits Application for Nasdaq Capital Market Up-Listing
Conversion Labs, Inc. (OTCQB: CVLB), a direct-to-consumer telemedicine and wellness company, has completed its previously announced equity investment by a select group of private investors and family offices, including investors David Blitzer and...
Sep 11, 2020 07:35 am ET
Conversion Labs August 2020 Revenues up 267% to Record $3.7 Million; Annualized Revenue Run-Rate Hit $44.0 Million
Conversion Labs, Inc. (OTCQB: CVLB), a direct-to-consumer telemedicine and wellness company, has reported record revenues of $3.7 million for the month of August, up more than 267% versus August 2019.  August results indicate an overall annualized...
Aug 31, 2020 05:00 pm ET
LD Micro 360 Companies Set to Present this Week
LOS ANGELES, CA / ACCESSWIRE / August 31, 2020 / LD Micro today announced the final list of companies slated to present at the upcoming LD 500, taking place September 1st-4th, 2020, exclusively online.
Aug 31, 2020 08:35 am ET
Conversion Labs Receives Commitment for $3.5 Million Equity Investment from Strategic Investors
Conversion Labs, Inc. (OTCQB: CVLB), a direct-to-consumer telemedicine and wellness company, announced that a select group of private investors and family offices have agreed to purchase $3.5 million of its newly issued Series B Convertible...
Aug 20, 2020 08:31 am ET
Conversion Labs to Present at the LD 500 Virtual Investor Conference on Sept. 1, 2020
NEW YORK, NY / ACCESSWIRE / August 20, 2020 / Conversion Labs, Inc. (OTCQB:CVLB), a direct-to-consumer telemedicine and wellness company, has been invited to present at LD Micro 500 virtual institutional investor conference being held on September 1-4, 2020.
Aug 17, 2020 10:18 am ET
Conversion Labs Q2 2020 Revenue up 237% to Record $9.1 Million; 2020 Revenue on Track to Exceed $40 Million
Conversion Labs, Inc. (OTCQB: CVLB), a direct-to-consumer telemedicine and wellness company, reported results for the second quarter and first half ended June 30, 2020. All quarterly and first half comparisons are to the same year-ago period unless...
Aug 05, 2020 09:00 am ET
LD Micro - Announces Preliminary List of Presenters for the LD-500
LOS ANGELES, CA / ACCESSWIRE / August 5, 2020 / LD Micro today announced the initial list of companies slated to present at the upcoming LD 500, taking place September 1st-4th, 2020, exclusively online.
Aug 03, 2020 08:31 am ET
Conversion Labs July 2020 Revenues up 302% to Record $3.6 Million, Remains on Track to Exceed $40 Million in Revenue in 2020
Conversion Labs, Inc. (OTCQB: CVLB), a direct-to-consumer telemedicine and wellness company, reported record revenues of $3.6 million in the month of July, up more than 302% versus July 2019. For July 2020, $1.2 million was attributed to recurring...
Jul 29, 2020 08:31 am ET
Conversion Labs to Host Second Quarter Conference Call on Monday, August 17, 2020 at 1:00 p.m. ET
Conversion Labs, Inc. (OTCQB: CVLB), a direct-to-consumer telemedicine and wellness company, will hold a conference call on Monday, August 17, 2020 at 1:00 p.m. Eastern time to discuss its results for the second quarter ended June 30, 2020. The...
Jul 16, 2020 08:09 am ET
SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating Conversion Labs, Inc. for Potential Breaches Of Fiduciary Duty By Its Board of Directors
NEW YORK, July 16, 2020 /PRNewswire/ -- Purcell Julie & Lefkowitz LLP, a class action law firm dedicated to representing shareholders nationwide, is investigating a potential breach of fiduciary duty claim involving the board of directors of Conversion Labs, Inc. (OTC: CVLB).
Jul 07, 2020 08:45 am ET
Conversion Labs Reports Preliminary Q2 2020 Revenues Climbing 241% to Record $9.2 Million; Raises 2020 Outlook to $40 Million+
Conversion Labs, Inc. (OTCQB: CVLB), a direct-to-consumer telemedicine and wellness company, reported preliminary unaudited results for its second quarter ended June 30, 2020. Revenues totaled approximately $9.2 million, up 114% sequentially and up...
Jun 16, 2020 08:31 am ET
Conversion Labs Appoints Leading Health & Wellness Doctor, Jeff Toll, to Medical Advisory Board
Conversion Labs, Inc. (OTCQB: CVLB), a direct-to-consumer telemedicine and wellness company, has appointed noted expert in internal medicine, Dr. Jeff Toll, to its medical advisory board.   As an industry thought-leader on holistic health and...
Jun 09, 2020 08:02 am ET
Conversion Labs Reports May 2020 Net Revenues up 274% to Record $3.2 Million, on Track to Exceed 3x Growth in 2020
Conversion Labs, Inc. (OTCQB: CVLB), a direct-to-consumer telemedicine and wellness company, reported record net revenues of $3.2 million for the month of May, up 274% versus May 2019. Combined net revenues for April and May totaled $6.3 million,...
May 19, 2020 03:00 pm ET
Conversion Labs Reports Revenue up 59% to Record $4.3 Million in Q1 2020; Raises 2020 Revenue Outlook to Exceed $36 Million
Conversion Labs, Inc. (OTCQB: CVLB), a direct-to-consumer telemedicine and wellness company, reported results for the first quarter ended March 31, 2020.  Q1 2020 Financial Highlights Revenue was a record $4.3 million, up 59% versus Q1 2019.Gross...
May 11, 2020 09:00 am ET
Conversion Labs Expands Capabilities of Telemedicine Platform as Sales in April More Than Double
Conversion Labs, Inc. (OTCQB: CVLB), a direct-to-consumer telemedicine and wellness company, has begun the roll out of a new cloud-based, end-to-end telemedicine platform, Veritas MD. The platform builds upon Conversion Labs’ existing telemedicine...
Apr 21, 2020 08:31 am ET
Conversion Labs Reports Preliminary First Quarter 2020 Revenue Up 60% to Record $4.3 Million
Conversion Labs, Inc. (OTCQB: CVLB), a direct-to-consumer telemedicine and wellness company, reported preliminary unaudited revenue of approximately $4.3 million for the first quarter ended March 31, 2020, up 60% compared to the same year-ago...
Apr 14, 2020 08:31 am ET
Conversion Labs Appoints Award-Winning Physician, Dr. Jeremy Fine, to Advisory Board to Advance Telemedicine Brand Portfolio
Conversion Labs, Inc. (OTCQB: CVLB), a direct-to-consumer telemedicine and wellness company, has appointed Dr. Jeremy Fine, a noted expert in internal medicine, to its medical advisory board. Dr. Fine will be involved in guiding and advancing...
Mar 31, 2020 09:29 am ET
Conversion Labs Reports Revenue up 81% to Record $3.9 Million in Q4 2019, up 50% to Record $12.5 Million for Full Year
Conversion Labs, Inc. (OTCQB: CVLB), a direct-to-consumer telemedicine and wellness company, reported results for the fourth quarter and full year ended December 31, 2019. Quarterly comparisons are to the same year-ago quarter. Financial...
Mar 26, 2020 08:31 am ET
Conversion Labs Receives FDA Clearance for Shapiro MD Laser Hair Restoration Device
Conversion Labs, Inc. (OTCQB: CVLB), a direct-to-consumer telemedicine and wellness company, has received FDA 510(k) clearance for its new hair regrowth product, the Shapiro MD Laser Hair Restoration Device. “This innovative, easy-to-use wearable...
Mar 23, 2020 08:31 am ET
Conversion Labs Donates 10,000 Bottles of Beta Glucan Immune Support Supplement to Healthcare Workers, First Line Responders, and COVID-19 Patients
Conversion Labs, Inc. (OTCQB: CVLB), a direct-to-consumer telemedicine and wellness company, is demonstrating its support for those leading the fight against COVID-19 and those diagnosed with the virus by giving away 10,000 bottles of its INR...
Mar 19, 2020 08:31 am ET
Conversion Labs Launches SOSRx Disaster Pack: Essential Prescription Medications for Disaster Scenarios Delivered via Telehealth
Conversion Labs, Inc. (OTCQB: CVLB), a direct-to-consumer telemedicine and wellness company, has officially launched its long-awaited new telemedicine brand, SOSRx. SOSRx is designed to deliver specially formulated combinations of prescription...
Mar 16, 2020 11:02 am ET
Conversion Labs Poised for Rapid Growth as Telemedicine Transforms Health & Wellness Market
Conversion Labs, Inc. (OTCQB: CVLB), a direct-to-consumer telemedicine and wellness company, is on track for a big leap in revenue growth this year due to some clear market foresight and a strategic decision to enter the telemedicine market early...
Mar 04, 2020 08:31 am ET
Conversion Labs to Present at the 32nd Annual ROTH Conference on March 15-17, 2020
Conversion Labs, Inc. (OTCQB: CVLB), a direct-to-consumer telemedicine and wellness company, has been invited to present at the 32nd Annual ROTH Conference being held at The Ritz Carlton, Laguna Niguel in Orange County, California, on March 15-17,...
Mar 02, 2020 08:31 am ET
Conversion Labs Pays off All Convertible Debt in Preparation for Growth and Market Expansion in 2020
Conversion Labs, Inc. (OTCQB: CVLB), a direct-to-consumer telemedicine and wellness company, has paid off all of its outstanding convertible notes totaling $1.52 million. The notes were paid from the proceeds of a term loan and a direct equity...
Feb 27, 2020 08:31 am ET
Conversion Labs Recaps 2019, Sees 145%+ Topline Growth in 2020
Conversion Labs, Inc. (OTCQB: CVLB), a direct-to-consumer telemedicine and wellness company, issued its 2020 shareholder letter today in which management highlighted the company’s strong growth since its transition to a direct-to-consumer business...
Jan 15, 2020 10:44 am ET
Conversion Labs Reports Preliminary 2019 Net Sales up 47% to Record $12.2 Million
Conversion Labs, Inc. (OTCQB: CVLB), a direct-to-consumer telemedicine and wellness company, reported preliminary unaudited net sales for the fourth quarter and full year ended December 31, 2019. For the fourth quarter of 2019, the company expects...
Dec 09, 2019 07:03 am ET
Conversion Labs to Present at the LD Micro Conference
Conversion Labs, Inc. (CVLB) (“Conversion Labs” or “Company”), an e-commerce and telemedicine company focused on building proprietary and personalized health and wellness brands, today announced that Justin Schreiber, Chairman and Chief Executive...
Dec 06, 2019 08:05 am ET
Conversion Labs Announces Official Launch of Men’s Telehealth Brand Rex MD
Conversion Labs, Inc. (CVLB) (“Conversion Labs” or “Company”), an e-commerce and telemedicine company focused on creating and scaling proprietary health and wellness brands, today announced its official launch of Rex MD, a male-oriented...
Nov 08, 2019 07:30 am ET
Conversion Labs Announces FDA 510(k) Submission for its Laser Therapy Hair Regrowth System
Conversion Labs, Inc. (CVLB) (“Conversion Labs” or “Company”), an e-commerce and telemedicine company focused on creating and scaling proprietary health and wellness brands, today announced it has filed a 510(k) submission with the U.S. Food and...
Nov 07, 2019 07:30 am ET
Conversion Labs Ranked Number 189 Fastest Growing Company in North America on Deloitte’s 2019 Technology Fast 500™
Conversion Labs, Inc. (CVLB) (“Conversion Labs” or “Company”), an e-commerce and telemedicine company focused on creating and scaling proprietary health and wellness brands, today announced it ranked #189 on Deloitte’s Technology Fast 500™, a...
Oct 18, 2019 07:37 am ET
Conversion Labs Reports LegitScript Certifications and Launch of Telemedicine Business
Conversion Labs, Inc. (CVLB) (“Conversion Labs” or “Company”), an e-commerce and telemedicine company focused on creating and scaling proprietary health and wellness brands, today announced receipt of LegitScript Certification for both Shapiro MD...
Oct 10, 2019 07:35 am ET
Conversion Labs Reports Record Third Quarter 2019 Revenue
Conversion Labs, Inc. (CVLB) (“Conversion Labs” or “Company”), an e-commerce and telemedicine company focused on creating and scaling proprietary health and wellness brands, today announced its unaudited financial results for the third fiscal...
Oct 07, 2019 08:09 am ET
Conversion Labs CEO Justin Schreiber Interviewed on NewsMax TV
Conversion Labs, Inc. (CVLB) (“Conversion Labs” or “Company”), an e-commerce and telemedicine company focused on building and scaling proprietary health and wellness brands, today announced that the Company’s Chairman and CEO, Justin Schreiber, was...
Sep 27, 2019 09:36 am ET
Conversion Labs Announces PDF Simpli Milestone of Over 2 Million Registered Users
Conversion Labs, Inc. (CVLB) (“Conversion Labs” or “Company”), an e-commerce and telemedicine company focused on building and scaling proprietary health and wellness brands, today announced that PDF Simpli achieved a milestone of over 2 million...
Sep 16, 2019 07:44 am ET
Conversion Labs to Present at the Fall Investor Summit on September 16th-17th in New York City
Conversion Labs, Inc. (CVLB) (“Conversion Labs” or “Company”), an e-commerce and telemedicine company focused on building and scaling proprietary online health and wellness brands, today announced that Justin Schreiber, Chairman and Chief Executive...
Aug 29, 2019 07:00 am ET
Conversion Labs Reports to Present at Upcoming Investor Conferences in September
Conversion Labs, Inc. (CVLB) (“Conversion Labs” or “Company”), an e-commerce and telemedicine company focused on building and scaling proprietary online health and wellness brands, today announced that the company plans to present at the following...
Aug 20, 2019 07:30 am ET
Conversion Labs Reports 32% Year-Over-Year Sales Growth; Announces Completion of Bridge Financing for $1.29 Million
Conversion Labs, Inc. (CVLB) (“Conversion Labs” or “Company”), an e-commerce and telemedicine company focused on building and scaling proprietary online brands, today reported financial results for the Second Quarter of 2019 and the six months...
Jun 11, 2019 07:30 am ET
Conversion Labs Strengthens Board of Directors with Appointment of Two New Directors
Conversion Labs, Inc. (OTCQB:CVLB) (the “Company” or “Conversion Labs”), an e-commerce company that builds proprietary consumer products and software brands, today announced that it has appointed Happy Walters and Bertrand Velge to its Board of...
Jun 04, 2019 07:00 am ET
Conversion Labs Announces Telemedicine Joint Venture and Strategic Partnership with GoGoMeds
Conversion Labs, Inc. (OTCQB:CVLB) (the “Company” or “Conversion Labs”), an e-commerce company focused on creating, acquiring and scaling proprietary consumer products and software, today announced that it has entered into a telemedicine joint...
May 01, 2019 07:30 am ET
Conversion Labs Announces PDF Simpli Achieves Milestone of Over 1 Million Registered Users
Conversion Labs, Inc. (CVLB) (“Conversion Labs” or “Company”), an e-commerce company focused on building and scaling innovative branded consumer products, today announced that the Company’s majority owned subsidiary, LegalSimpli Software LLC,...
Apr 10, 2019 11:59 am ET
Conversion Labs to Host Conference Call This Afternoon to Discuss FY 2018 and 2019 Expectations
Conversion Labs, Inc. (CVLB) (“Conversion Labs” or “Company”), an e-commerce company focused on building and scaling innovative branded consumer products, will be hosting a conference call today to discuss the results of Fiscal Year 2018,...
Apr 08, 2019 07:23 am ET
Conversion Labs Announces Record Monthly and Quarterly Sales; Results To Be Discussed In Upcoming Conference Call
Conversion Labs, Inc. (CVLB) (“Conversion Labs” or “Company”), an e-commerce company focused on building and scaling innovative branded consumer products, today announced record sales for the month of March 2019 and for the First Quarter of 2019....
Apr 04, 2019 08:59 am ET
Conversion Labs to Host Conference Call on April 10 2019 to Discuss Fiscal Year 2018 Results
Conversion Labs, Inc. (OTCQB:CVLB) (“Conversion Labs” or “Company”), an e-commerce company focused on building and scaling innovative branded consumer products, will be hosting a conference call to discuss its corporate and financial results for...
Mar 22, 2019 07:30 am ET
Conversion Labs Announces Robust Sales Traction To Start 2019
Conversion Labs, Inc. (OTCQB:CVLB) (“Conversion Labs” or “Company”), an e-commerce company focused on building and scaling innovative branded consumer products and software, today announced promising sales data to start 2019, driven by sales of the...
Nov 20, 2018 07:15 am ET
Conversion Labs’ Recognized In Deloitte’s “Technology Fast 500” Ranking
Conversion Labs, Inc. (OTCQB:CVLB) (“Conversion Labs” or “Company”), an e-commerce company focused on building and scaling innovative branded consumer products and software, today announced that the Company was included in Deloitte’s Technology...
Nov 16, 2018 07:38 am ET
Conversion Labs Reports Record-Breaking Quarterly Results
Conversion Labs, Inc. (OTCQB:CVLB) (“Conversion Labs” or “Company”), an e-commerce company focused on building and scaling innovative branded consumer products and software, today reported financial results for the third quarter of 2018 and nine...
Oct 16, 2018 07:30 am ET
Conversion Labs Reports Preliminary Sales Up 72% During First 9 Months of 2018 Compared to the Same Period in 2017
Conversion Labs, Inc. (OTCQB:CVLB) (“Conversion Labs” or “Company”), an e-commerce company focused on building and scaling innovative branded consumer products, today reported preliminary revenue results for the third quarter of 2018 and nine...
Oct 04, 2018 07:30 am ET
Conversion Labs Announces Endorsement Agreement with Renowned Microbiologist Jack Gilbert
Conversion Labs, Inc. (OTCQB:CVLB) (“Conversion Labs” or “Company”), an e-commerce company focused on building and scaling innovative branded consumer products, today announced it has reached an endorsement agreement for iNR Wellness with Jack...
Sep 06, 2018 08:09 am ET
Conversion Labs’ Newest Product Purpurex on Schedule for Imminent Launch
Conversion Labs, Inc. (OTCQB:CVLB) (“Conversion Labs” or “Company”), an e-commerce company focused on building and scaling innovative branded consumer products, today announced an update on the upcoming launch of Purpurex®. The Company anticipates...
Aug 21, 2018 08:50 am ET
Conversion Labs Reports 208% Q/Q Sales Growth; Profitability Anticipated In Q3
Conversion Labs, Inc. (OTCQB:CVLB) (“Conversion Labs” or “Company”), an e-commerce company focused on building and scaling innovative branded consumer products, today reported financial results for the second quarter of 2018 and six months ended...
Aug 13, 2018 08:24 am ET
Conversion Labs Announces Strong Commercial Launch for PDFSimpli
Conversion Labs, Inc. (OTCQB:CVLB) (“Conversion Labs” or the “Company”), an e-commerce company that builds and scales innovative and high quality brands, today announced preliminary data from the commercial launch of PDFSimpli, the Company’s newest...
Jul 26, 2018 07:44 am ET
Conversion Labs Announces Sean Fitzpatrick as Chief Acquisition Officer
Conversion Labs, Inc. (OTCQB:CVLB) (the “Company”), an e-commerce company that builds and scales innovative brands, today announced the appointment of seasoned direct response marketing expert Sean Fitzpatrick to serve as the company's new Chief...
Jul 24, 2018 08:06 am ET
Conversion Labs Expands to Asia Pacific Through Joint Venture
Conversion Labs, Inc. (OTCQB:CVLB) (the “Company”), an e-commerce company that builds and scales innovative brands, today announced expansion in the Asia Pacific region through the formation of a new 50-50 joint venture. Conversion Labs Asia Ltd.,...
Jul 11, 2018 07:00 am ET
Conversion Labs Reports 89% Increase in Preliminary Revenues During Second Quarter 2018
Conversion Labs, Inc. (OTCQB:CVLB) (the “Company”), an e-commerce company that builds and scales innovative brands, today announced preliminary revenues of approximately $2.1 million for the second quarter of 2018 and $3.7 million for the first six...
Jul 10, 2018 07:00 am ET
Immudyne, Inc. Announces Name Change & Rebranding to Conversion Labs, Inc.
Conversion Labs, Inc (formerly Immudyne, Inc.,) (the “Company” or “Conversion Labs”) is pleased to announce its formal name change to Conversion Labs, Inc. As part of the rebranding, the Company is now trading under the new ticker symbol “CVLB”...

Thank you for visiting InsiderTracking.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you wish to consider using a browser that blocks ads, please log in or subscribe.

Alternatively, if you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). If you are in private browsing mode and do not want to subscribe, please disable tracking protection while visiting our website.

Thank you for using Insider Tracking.